Episode Details

Back to Episodes

Episode 066: The Future of Pharmacy: AI, Technology & Personalized Medicine

Episode 66 Published 2 days, 13 hours ago
Description

What does the future of pharmacy look like when artificial intelligence meets personalized medicine?

In this episode of The Irsfeld Pharmacy Optimal You Podcast, pharmacist Steve Irsfeld welcomes Dr. Peter Koshland, PharmD, founder and CEO of Koshland Pharmacy in San Francisco and PCCA's 2025 U.S. Compounding Pharmacist of the Year.

Together, they explore how artificial intelligence, emerging technologies, and personalized compounding are changing the way independent pharmacies operate, and what those advancements could mean for patients.

Peter shares how his pharmacy is already using AI to support clinical consultations, organize years of professional knowledge, and help pharmacists make more informed recommendations. They also discuss the possibilities of 3D printing, robotics, and other technologies that could improve efficiency while allowing pharmacists to focus more on individualized care.

In this episode, you'll learn about:

  • How AI is being used in independent pharmacies today

  • Why personalized medicine depends on relationships between pharmacists, prescribers, and patients

  • How technology can help pharmacists access information and make clinical decisions more efficiently

  • The potential of 3D printing and robotics in pharmaceutical compounding

  • Why human expertise and professional judgment remain essential as AI advances

  • One simple health priority that shouldn't be overlooked: getting enough quality sleep

While technology continues to evolve, Steve and Peter agree on one important principle: innovation should ultimately serve the patient.

Discover how the future of pharmacy may combine smarter tools with something that has always mattered—personal attention, professional expertise, and a commitment to better health.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us